Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/44190
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12904]
Metadata
Show full item record
PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG HEMOPHILIACS IN CENTRAL BRAZIL
Author
Affilliation
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Universidade Federal de Goiás. Instituto de Patologia Tropical e Saúde Pública. Goiânia, GO, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ, Brasil.
Abstract
In order to investigate the hepatitis C virus (HCV) infection prevalence and risk factors in hemophiliacs in
Central Brazil, 90 patients were interviewed and serum samples tested for HCV RNA and anti-HCV antibodies. An
overall prevalence of 63.3% (CI 95%: 53.0-72.7) was found. Multivariate analysis of risk factors showed that
number of blood transfusions was significantly associated with this infection. Most hemophiliacs received locally
produced cryoprecipitate. All infected patients were transfused before the screening of blood units for anti-HCV.
However, hemophiliacs who received exclusively screened cryoprecipitate were HCV negative. It confirms the
expected decline in transfusion-acquired hepatitis C.
Share